Glesatinib
Product Specifications
CAS Number
936694-12-1
Synonyms
MGCD265
Target
C-Met
Applications
Protein Tyrosine Kinase
Molecular Formula
C31H27F2N5O3S2
Additionnal Information
Glesatinib (MGCD265) is an orally bioavailable potent dual inhibitor of c-MET and SMO. Glesatinib counteracts P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) .
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA506085BM 100 µL
RARRES1 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI2E12]
Sign In for Pricing
View Details 
MBS6197143-01 0.1 mL
PCBP2 (poly(rC) Binding Protein 2, HNRPE2, MGC110998, hnRNP-E2) (MaxLight 405)
Sign In for Pricing
View Details MBS6197143-02 5x 0.1 mL
PCBP2 (poly(rC) Binding Protein 2, HNRPE2, MGC110998, hnRNP-E2) (MaxLight 405)
Sign In for Pricing
View Details